Scientific efforts aiming at dissecting the cancer biology of TNBC have revealed several promising therapeutic targets including epidermal growth factor receptor (EGFR), a critical membrane-bound receptor tyrosine kinase for cancer progression. The gene discussed is EGFR; the disease is cancer.